Cargando…
Comparison of stent and indomethacin suppository efficacy in the prevention of acute pancreatitis after ERCP
OBJECTIVE: We aimed to compare stent and indomethacin suppository efficacy in the prevention of acute pancreatitis after ERCP. MATERIALS AND METHODS: 76 high-risk patients undergoing ERCP were included in the study. The patients were divided into three groups as indomethacin group, stent group and c...
Autores principales: | Icacan, Gamze, Onalan, Erhan, Yucesoy, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477098/ https://www.ncbi.nlm.nih.gov/pubmed/34487093 http://dx.doi.org/10.23750/abm.v92i4.10962 |
Ejemplares similares
-
MRI Evaluation of Indomethacin Suppositories in the Prevention of Complications of Pancreatitis and Hyperamylasemia after Choledocholithiasis ERCP Based on Image Denoising Algorithm
por: Gao, Fusheng, et al.
Publicado: (2022) -
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021) -
Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial
por: Elmunzer, B. Joseph, et al.
Publicado: (2016) -
Correction to: Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial
por: Elmunzer, B. Joseph, et al.
Publicado: (2020) -
Pancreatic Stent or Rectal Indomethacin—Which Better Prevents Post-ERCP Pancreatitis?: A Propensity Score Matching Analysis
por: Li, Guo-Dong, et al.
Publicado: (2016)